Learning Objectives

At the end of the 2026 CRS Annual Meeting, participants will be able to:

1

Review current advances in the medical management of retinal diseases, including emerging pharmacologic therapies and evolving treatment strategies for age-related macular degeneration, diabetic macular edema, and retinal vein occlusion

2

Interpret advanced retinal imaging and clinical biomarkers to enhance diagnostic accuracy, disease monitoring, and therapeutic decision-making

3

Discuss contemporary surgical techniques and clinical decision-making in vitreoretinal surgery, including management strategies for retinal detachment, macular holes, and complex vitreoretinal conditions

4

Evaluate emerging technologies and innovations including artificial intelligence, gene therapy, and novel therapeutic platforms that may influence future clinical retina practice

Accreditation

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by the Canadian Ophthalmological Society (COS). You may claim a maximum of 9 hours (credits are automatically calculated). The specific opinions and content of this event are not necessarily those of COS, and are the responsibility of the organizer(s) alone.

Agenda

Friday, April 17, 2026

PLENARY SESSION #1 – SURGERY I
Cinema – first floor
Co-chairs: Keyvan Koushan, MD & Bernard Hurley, MD

3:30 PM	Welcome and Opening Remarks Co-chairs: Bernard Hurley, MD; Keyvan Koushan, MD
3:40 – 4:35 PM	Surgical Video Session: East vs West Moderators: Amin Kherani, MD and David Wong, MD
4:40 – 4:50 PM	Congenital Vitreoretinal Disorders Audina Berrocal, MD
4:52 – 5:02 PM	Power of Vitrectomy Cutter Biopsy Hung-Da Chou, MD
5:02 – 5:12 PM	Myopic Traction Maculopathy Surgery: A Beginner's Guide Hung-Da Chou, MD
5:12 – 5:30 PM	Q&A
6:00 PM	Welcome Reception – New Fort Hall

Saturday, April 18, 2026

7:00 AM

Breakfast – Princes' Gate Pre-function Area / Princes' Gate Ballroom

PLENARY SESSION #2 – ANTI-VEGF
Cinema – first floor
Moderators: Jason Noble, MD & Radha Kohly, MD, PhD

8:30 – 8:35 AM	Welcome and Review of Agenda Bernard Hurley, MD; Keyvan Koushan, MD
8:35 – 8:45 AM	Biomarkers in Diabetic Macular Edema Adrian Koh Hock Chuan, MD, MBBS
8:47 – 8:55 AM	SPECTRUM: First Canadian Real‑world Outcomes with Aflibercept 8 mg in Previously Treated Diabetic Macular Edema Keyvan Koushan, MD
8:57 – 9:05 AM	Long-term Canadian Real-world Experience With Faricimab in Patients with Neovascular Age-related Macular Degeneration and Diabetic Macular Edema Parth Shah, MD
9:06 – 9:11 AM	Introduction to Mila Oh Memorial Talk John Chen, MD
9:13 – 9:23 AM	Mila Oh Memorial Talk: Battle of the Next Generation Therapies John Kitchens, MD
9:24 – 9:32 AM	Aflibercept 8 mg in Retinal Vein Occlusion: Final Results from the QUASAR Study Varun Chaudhary, MD
9:33 – 9:41 AM	SPECTRUM: First Canadian Real‑world Outcomes With Aflibercept 8 mg in Previously Treated Neovascular Age-related Macular Degeneration Raman Tuli, MD
9:42 – 9:52 AM	Current Management of Polypoidal Choroidal Vasculopathy in 2026 Adrian Koh Hock Chuan, MD, MBBS
9:52 – 10:05 AM	Q&A
10:15 ‒ 11:00 AM	For more details, click here
11:00 ‒ 11:25 AM	Break – Poster Session – Princes' Gate Pre-function Area POSTER SESSION – Library Collection Lounge

PLENARY SESSION #3 – SURGERY II
Cinema – first floor
Moderators: Varun Chaudhary, MD & Wai-Ching Lam, MD

11:30 – 11:40 AM	Lamellar Macular Holes - What's Going On and What Should We Do? David Steel, MBBS, MD(Res)
11:42 – 11:50 AM	Is 20/20 Vision Good Enough? Outcomes of Complete Pars Plana Vitrectomy During IOL Exchange for Lens Opacification in Patients with Preserved Visual Acuity Robert Gizicki, MD
11:52 AM – 12:00 PM	Suprachoroidal Viscopexy for Rhegmatogenous Retinal Detachment: Two-year Safety and Efficacy Outcomes Aurora Pecaku, MD
12:00 – 12:10 PM	Q&A
12:12 – 12:20 PM	Pneumatic Retinopexy as a Temporizing Treatment Strategy for Retinal Detachment: A Population-based Cohort Study Gareth Mercer, MD, PhD
12:22 – 12:30 PM	Vitrectomy After Successful Pneumatic Retinopexy for Rhegmatogenous Retinal Detachment Robert Gizicki, MD
12:32 – 12:42 PM	Tamponade Choice with Vitrectomy for Rhegmatogenous Retinal Detachment; Does It Make a Difference? David Steel, MBBS, MD(Res)
12:40 – 12:50 PM	Q&A
12:50 – 1:35 PM	LUNCH – Princes' Gate Pre-function Area / Princes' Gate Ballroom POSTER SESSION – Library Collection Lounge
1:35 ‒ 2:15 PM	For more details, click here

PLENARY SESSION #4 – POTPOURRI
Cinema – first floor
Moderators: Geoff Williams, MD & Shaheer Aboobaker, MD

2:25 – 2:35 PM	What in the World is Going on in the United States? John Kitchens, MD
2:37 – 2:45 PM	In Vivo Assessment of Peripheral Vitreous Traction with Ultra-widefield Swept-source OCT in Rhegmatogenous Retinal Detachment Isabela Martins Melo, MD
2:47 – 2:57 PM	Pediatric Retina Detachment Audina Berrocal, MD
2:57 – 3:07 PM	Q&A
3:09 – 3:19 PM	Retinopathy of Prematurity in 2026 Audina Berrocal, MD
3:21 – 3:29 PM	Comparative Outcomes of Secondary Intraocular Lens Fixation Techniques Kirill Zaslavsky, MD
3:31 – 3:39 PM	Comparison of Clinical Outcomes of Sutureless Flanged Intrascleral (Yamane) and Four-point Gore-Tex Suture Techniques for Intraocular Lens Fixation Robert Gizicki, MD
3:39 – 3:45 PM	Q&A
3:50 ‒ 4:35 PM	For more details, click here
4:35 – 5:00 PM	BREAK – Princes' Gate Pre-function Area / Princes' Gate Ballroom POSTER SESSION – Library Collection Lounge
5:00 – 5:45 PM	CRS Annual General Meeting
6:30 PM	RECEPTION – Princes' Gate Pre-function Area GALA – Princes' Gate Ballroom

Sunday, April 19, 2026

7:00 AM

Breakfast – Princes' Gate Pre-function Area / Princes' Gate Ballroom

PLENARY SESSION #5 – AGE-RELATED MACULAR DEGENERATION
Cinema – first floor
Moderators: Amin Kherani, MD & David Maberley, MD

8:35 – 8:45 AM	How to Assess Functional Loss and Progression in Geographic Atrophy Ursula Schmidt-Erfurth, MD
8:47 – 8:55 AM	One Year Results of a Phase 2 Pharmacodynamic Study: Subretinal Delivery of Investigational Gene Therapy Sura-vec (ABBV-RGX-314) for Neovascular Age-related Macular Degeneration Robert Gizicki, MD
8:57 – 9:05 AM	Reduction in Subretinal Hyperreflective Material Volume with Faricimab vs Aflibercept 2 mg in Treatment-naïve Neovascular Age-related Macular Degeneration: A TENAYA/LUCERNE Post Hoc Analysis Nirojini Sivachandran, MD, PhD
9:05 – 9:10 AM	Q&A
9:10 – 9:20 AM	How do You Diagnose Polypoidal Choroidal Vasculopathy Without Indocyanine Green Angiography? Adrian Koh Hock Chuan, MD, MBBS
9:22 – 9:30 AM	Avacincaptad Pegol for Geographic Atrophy: 3.5-Year Results from the GATHER2 Open-label Extension Trial Varun Chaudhary, MD
9:32 – 9:42 AM	Age-related Macular Degeneration as a Complex Disease Between Atrophy and Neovascularization Ursula Schmidt-Erfurth, MD
9:42 – 10:00 AM	Q&A
10:00 – 10:30 AM	BREAK – Princes' Gate Pre-function Area / Princes' Gate Ballroom POSTER SESSION – Library Collection Lounge

PLENARY SESSION #6 – Artificial Intelligence
Cinema – first floor
Moderators: Varun Chaudhary, MD & Peter Kertes, MD

10:32 – 10:42 AM	Practical Ways to Use Existing AI in Clinic David Steel, MBBS, MD(Res)
10:44 – 10:52 AM	Baseline Peripheral Vascular Leakage is Linked to Treatment Response in Patients With Central Retinal Vein Occlusion: A Pilot Study Alan Cruess, MD
10:54 – 11:02 AM	Subretinal Delivery of Investigational Sura-vec (ABBV-RGX-314) as a Gene Therapy Shaheer Aboobaker, MD
11:04 – 11:14 AM	AI as a Management Tool for Neovascular Age-related Macular Degeneration Ursula Schmidt-Erfurth, MD
11:14 – 11:20 AM	Q&A

PLENARY SESSION #7 – Surgery III
Cinema – first floor
Moderators: Keyvan Koushan, MD & Bernard Hurley, MD

11:25 – 11:35 AM	How Should We Treat Refractory Macular Holes? David Steel, MBBS, MD(Res)
11:37 – 11:44 AM	Predictors of Primary Anatomic Reattachment With Pneumatic Retinopexy for Rhegmatogenous Retinal Detachment Aurora Pecaku, MD
11:46 – 11:54 AM	Outer Retinal Corrugations Indicate Retinal Break Status in Rhegmatogenous Retinal Detachment Jeffrey Mah, MD
11:56 AM – 12:06 PM	Double the Adjuncts, Double the Confidence in Macular Surgery Hung-Da Chou, MD
12:06 – 12:20 PM	Q&A
12:20 PM	Concluding Remarks Bernard Hurley, MD, and Keyvan Koushan, MD
12:30 PM	GRAB & GO LUNCH (LOCATED OUTSIDE CINEMA)

Annual Meeting Agenda

All Sessions: Cinema - Ground Floor

Note: this meeting will take place in English.

Guest Speakers:

Robyn Guymer, AM, MBBS, PhD, FRANZCO, FAHMS
Professor of Ophthalmology
Melbourne University
Deputy Director
Centre for Eye Research Australia
Melbourne, Victoria, Australia

Sobha Sivaprasad, MBBS, FRCS, FRCOphth
Medical Retina Consultant Ophthalmologist
Moorfields Eye Hospital NHS Foundation Trust
Professor in Retinal Clinical Research
University College London
London, United Kingdom

Carl D. Regillo, MD, FASRS
Professor of Ophthalmology
Thomas Jefferson University
Chief, Retina Service, and Founder
Wills Eye Clinical Retina Research Unit, Wills Eye Hospital

Sunil K. Srivastava, MD
Staff Physician
Cole Eye Institute, Cleveland Clinic
Cleveland, Ohio

Friday, May 12

PLENARY SESSION #1 – COAST-TO-COAST RETINA CHECKUP PART 1 SURGERY
Moderators: Bernard Hurley, MD, and Robert Gizicki, MD

3:30 pm Welcome and Opening Remarks

3:40 pm Vitreoretinal Surgical Video Session: “Masters of Disasters”
David Wong, MD
Q&A (included)

4:25 pm Vitreoretinal Surgery in Uveitis
Sunil Srivastava, MD

4:40 pm Q&A Session

4:45 pm Pearls in Pediatric Retina Surgery
Cynthia Qian, MD

4:51 pm Complex Vitreoretinal Surgery
Flavio Rezende, MD, PhD

4:57 pm Bacillary Layer Detachment in the Pathophysiology of Secondary Macular Hole in Fovea-off Rhegmatogenous Retinal Detachment
Isabela M. Melo, MD

5:03 pm Q&A

5:11 pm Efficacy and Safety of Proposed MYL-1701P Biosimilar Compared to Eylea® (Reference Aflibercept) in Diabetic Macular Edema: A Randomized, Double-masked, Phase 3 Equivalence Study (INSIGHT Study)
Susan B. Bressler, MD

5:17 pm 2-Year Evaluation of Subretinal Fluid Drainage Techniques in Pars Plana Vitrectomy for Primary Rhegmatogenous Retinal Detachment
(ELLIPSOID-2 Study)
Aditya Bansal, MD

5:23 pm Lenses for Pars Plana Scleral Fixation
Amar Mannina, MD

5:29 pm Q&A

5:37 pm Session 1 Concluding Remarks
Moderators: Bernard Hurley, MD, and Robert Gizicki, MD

6:00 pm Welcome Reception - Princes' Gates Ballroom

Saturday, May 13

7:00 am BREAKFAST – Princes’ Gates Ballroom

7:30 am SATELLITE SYMPOSIUM – Cinema Ground Floor

PLENARY SESSION #2 – AGE-RELATED MACULAR DEGENERATION & DIABETIC MACULAR EDEMA
Moderators: Varun Chaudhary, MD, and Jason Noble, MD

8:30 am Introduction to Section 2

8:40 am Reticular Pseudodrusen – A Critical Phenotype
Robyn Guymer, AM, PhD

8:55 am Q&A

9:02 am Tyrosine Kinase Inhibition for nAMD Clinical Trial Studies
Carl Regillo, MD

9:17 am Q&A

9:24 am Early OCT Signs of Atrophy in AMD
Robyn Guymer, AM, PhD

9:39 am Q&A

9:46 am Translating Clinical Trials to Practice in Geographic Atrophy
Sobha Sivaprasad, MBBS

10:01 am Q&A

10:08 am VOYAGER: An Innovative Real-world Study of Faricimab and the Port Delivery System with Ranibizumab in Patients with nAMD and DME
Robyn Guymer, AM, PhD

10:23 am Q&A

10:30 am BREAK – Princes’ Gates Ballroom Pre-function Area, 3^rd Floor
Poster Session

PLENARY SESSION #3 – Retinal Vascular Disease
Moderators: Bernard Hurley, MD, and Robert Gizicki, MD

11:00 am Introduction to Session 3

11:05 am Choice of Agent in CRVO
Sobha Sivaprasad, MBBS

11:15 am Q&A

11:22 am CRAO Management and CRAO Masquerades
Sunil Srivastava, MD

11:37 am Q&A

11:44 am Where Do We Place Biosimilars in Our DME Treatment Algorithm?
Sobha Sivaprasad, MBBS

12:00 pm Q&A

12:07 pm Discontinuous Versus Continuous Treatment for DME: Evidence Review and Evidence Generation
Varun Chaudhary, MD

12:22 pm Q&A

12:30 pm LUNCH – Princes’ Gates Ballroom

1:15 pm SATELLITE SYMPOSIUM – Cinema Ground Floor

PLENARY SESSION #4 – Surgery
Moderator: Bernard Hurley, MD, and Wai-Ching Lam, MD

2:15 pm Introduction to Session 4

2:20 pm Perfluorocarbon Liquid in Retinal Detachment Repair: Pearls and Pitfalls
Carl Regillo, MD

2:35 pm Q&A

2:42 pm Mila Oh Memorial Lecture: Diagnosis and Management of Diabetic Retinopathy in 2030
Sobha Sivaprasad, MBBS

2:57 pm Q&A

3:04 pm The Surgical Management of Inherited Retinal Diseases
Peter Kertes, MD

3:19 pm Q&A

3:26 pm Gene Therapy for Neovascular AMD and Diabetic Retinopathy
Carl Regillo, MD

3:41 pm Q&A

3:48 pm BREAK – Princes’ Gates Ballroom Pre-function Area, 3^rd Floor
Poster Session

PLENARY SESSION #5 – Uveitis
Moderators: Phil Hooper, MD, and Robert Gizicki, MD

4:15 pm Introduction to Session 5

4:25 pm Masquerade Syndromes, New Treatment in Uveitis Imaging
Sunil Srivastava, MD

4:40 pm Q&A

4:47 pm Clinical and Imaging Pearls in Uveitis
Nupura Bakshi, MD

5:02 pm Q&A

5:15-6:00 pm CRS Annual General Meeting – Cinema Ground Floor

6:30 pm GALA – Princes’ Gates Ballroom

Sunday, May 14

7:30 am BREAKFAST

PLENARY SESSION #6 – Coast-to-Coast Part 2 Medical Retina
Moderators: Bernard Hurley, MD, and Robert Gizicki, MD

8:45 am Introduction to Session 6

8:50 am Pachychoroid Spectrum Diseases
Wai-Ching Lam, MD

8:56 am Scleral Buckle Techniques
Geoff Williams, MD

9:02 am Exciting and New
Mark Greve, MD

9:08 am Does Anti-VEGF Treatment Impact Retinal Nonperfusion in Diabetic Retinopathy?
Varun Chaudhary, MD

9:14 am Q&A

9:30 am SPONSORED SYMPOSIUM – Cinema Ground Floor

10:30 am BREAK – Trillium Park Studio, 3^rd Floor
Poster Session

10:45 am Assessment of Geographic Atrophy Progression in the Phase 3 OAKS and DERBY Trials
Tom Sheidow, MD

10:51 am Retinal Displacement After Scleral Buckle Versus Combined Buckle and Vitrectomy for Rhegmatogenous Retina Detachment: ALIGN SB vs PPV-SB
Aditya Bansal, MD

10:57 am The Long-term Structural and Functional Impact of Retinopathy of Prematurity
Cynthia Qian, MD

11:03 am Delayed Near InfraRed Analysis (DNIRA) Identifies Novel Features of Nonexudative (Dry) AMD in a Prospective, Natural History Study
Filiberto Altomare, MD

11:09 am Q&A

11:24 am Concluding Remarks
Co-chairs: Bernard Hurley, MD, and Robert Gizicki, MD

12:00 pm LUNCH – Princes’ Gates Ballroom

Posters

Efficacy and Safety of Pars Plana Vitrectomy for Primary Symptomatic Vitreous Floaters: A Systematic Review and Meta-Analysis
Ahmad, A; Kailani, Z; Bakar Butt, A; Tao, BK; Pandya, BU; Pereira, A; Tang, T; Popovic, M; Arjmand, P; Yan, P; Kherani, A; Kertes, P.
Pregnancy-Associated Bilateral Central Retinal Vein Occlusion and Diabetic Retinopathy: A Trimester-Sensitive Approach
Ahmad, A; Ji, P; Sivachandran, N.
Real-Time Closed-Loop Simulator for Cortical Visual Prosthetics Using Neural-State Modulation
Mouawad, A; Chen, J.
Prognostic Value of Widefield Fluorescein Angiography for Systemic Immunomodulatory Therapy Initiation and Visual Acuity Outcomes in Patients with Non-Infectious Uveitis
Pereira, A; Kherani, I; Tang, T; Al-Ghafri, M; Felfeli, T; Christakis, P; Kaplan, AJ; Derzko-Dzulynsky, L; Yan, P; Bakshi, NK.
High-Accuracy Automated Detection of Outer Retinal Tubulations on OCT Using a Deep Learning Model
Zhang, E-R; Mouawad, A; Al-Khuzaei, S; Deud, B; Ayalon, A; Chen J.
Incidence of delayed retinal tears and retinal detachments in initial uncomplicated cases of posterior vitreous detachments
Lau, A; Zhang, E-R; Chaker, A; Zwaig, J; Chow, D; Chen J.
Short-Term Outcomes of Switching to Faricimab in nAMD and DME Patients with Suboptimal Responses to Aflibercept
Zhang, E-R; Ayalon, A; Al Ghafri, M; Kapusta, M; Lederer, DE; Galic, IJ; Chen, J.
Ellipsoid Zone Loss as a Retinal Complication after Chimeric Antigen Receptor T-Cell Therapy: A Case Report
Zhang, E-R; Lederer, DE.
Increasing Subretinal Fluid over a Stable Choroidal Nevus Unmasking an Overlying Retinal Tear - A Diagnostic Pitfall: A Case Report
Daud, F; Pandya, BU; Tang, T; Krema, H; Altomare, F; Yan, P.
Visually Predictive Biomarkers on OCTA following Anti-VEGF treatment of Retinal Vein Occlusion - A Systematic Review
King, S; Daud, F; Kowal, S; Lai, A; Loewen, D; Weng, N; Qiu, W; Nanji, K; Wahab, C ; Yan, P.
Intraoperative Intraocular Pressure Management During Vitreoretinal Surgery: A Survey of Canadian Vitreoretinal Surgeons
Ling, JYM; Cai, C; Mammo, Z; Lam, W-C.
Defining Intraocular Safety Limits for Povidone-Iodine Irrigation: A Concentration- and Time-Dependent Study in Rats
Huo, L; Cioana, M; Ware, M; Shoichet, M; Yan, P.
Age-Related Choroidal Atrophy (ARCA): A Systematic Review of Multimodal Imaging, Clinical Features, and Differentiation from AMD and GA
Lai, A; Pereira, A; Issa, M; Al Ghafri, M; Dollin, M; Hurley, B; MD FRCSC⁴, Jay Chhablani, J; Yan, P.
Macular and Retinal Manifestations Following COVID-19 Vaccinations: A 2025 Update Systematic Review and Meta-Analysis
Ji, PX; Krishnan, AR; Famiyeh, I-M; Ahmad, A; Sivachandran, N.
Carbon Footprint of Pars Plana Vitrectomy, Pneumatic Retinopexy and Scleral Buckle for Rhegmatogenous Retinal Detachment Repair
Moorjani, R; Loh, GK; Tennant, MTS; Kertes, PJ; Grewal, PS.
A Novel Interactive Functional Vision Test to Visualize Patient-Perceived Vision in Retinal Disease: A Proof of Concept Pilot Study
Sabour, S; Pecaku, A; Martins Melo, I; Ortin-Martinez, A; Muni, RH; P Kohly, RP.
Comparative Analysis of Subretinal Fluid Characteristics in Regulated and Dysregulated Rhegmatogenous Retinal Detachment
Sabour, S; Pecaku, A; Martins Melo,I; Karla, R; Muni, RH.
High-Resolution Visualization of Posterior Vitreous Using Swept-Source OCT and Custom Software Enhancement
Sabour, S; Pecaku, A; Martins Melo, I; Muni, RH; Wong, DT.
Selective Therapeutic Response to Faricimab in a Coats’ Disease Variant with Cystoid Macular Edema
Rotholz, T; Kim, GE; Ji, PX; Sivachandran, N.
Non-Surgical Treatment of Full Thickness Macular Holes: A Systematic Review
Miller, T; Kamali Zonouzi, S; Arjmand, P.
Unexplained Vision Loss Following Silicone Oil Removal: A Systematic Review and Meta-Analysis
Yu, P; Mofid, K; Naveed, F; Huo, L; Tao, BK; Pereira, A; Tang, T; Lam, W-C; Mandelcorn, ED; Wong, DT; Yan, P.
Case Report: A Different Kind of Oil Removal
Kherani, A.
Prospective Evaluation of Choroidal Compartments and Vascularity Index in Rhegmatogenous Retinal Detachment Using Swept-Source OCT
Pecaku, A; Martins Melo, I; Samet, S; Sabour, S; Zaman, M; Kirk, C; Mohammed, AR; Chhablani, J; Muni, RH.
Rare, and New, Causes of Tapetal-like Retinal Sheen
Ballios, BG; Kodida, R; Zhai, Y.
Early Canadian Faricimab Experience in Patients With Neovascular Age-related Macular Degeneration or Diabetic Macular Edema Previously Treated With Bevacizumab Only
Gizicki, R; Tuli, R; Sivachandran, N; Aboobaker, S; Ta Kim, D; Koushan, K; Levasseur, SD; McLaughlin, A; Wittenberg, L; Lee, T; Abbas, K; Baker, J; Aboukarr, A; Alexander, J; Park, JG.
SPECTRUM: First Canadian RealWorld Outcomes With Aflibercept 8 mg in Previously Treated Neovascular Age-related Macular Degeneration
Tuli R; Chaudhary, V; Mok, A; Soliman, K; on behalf of the SPECTRUM study investigators.
Anatomical Success and Visual Improvement After Macular Hole Repair Procedures: A Retrospective Analysis from a Canadian Ambulatory Surgery Center
Naveed, F; Rotholz, T; Khannejad, S; Hashemi, E; Kunde, H; Hwang, K; Aksoy, U; Mohammed, AR; Aboobaker, S.
Study Design and Rationale of the FARTHER Study: A Single-arm, Open-label, Multicenter Study Investigating the Switch to Faricimab in Responsive Aflibercept nAMD Patients
Chaudhary, V; Kertes, P; Baker J.
Modified Technique for Intrascleral Haptic Fixation of Posterior Intraocular Lenses
Zarza, V; Williams, G; Olson, K; Azarcon, C; Kherani, S.
Anesthetic Practices in Vitreoretinal Surgery: A Study on Retrobulbar Anesthesia and Monitored Anesthesia Care
Ayalon, A; Zhang, E-R; Wasser, LV; La Mantia, A; Deud, B; Kapusta, MAA.
Comparing NEI-VFQ-25 Scores Administered in Clinic and Online in Individuals With Vision Impairment
Thomas, A; Thangavadivelu, L; Moniz, L; Mikhail, D; Tuli, R; Wong, DT; Qian, C; Sivachandran, N.